MedPath

Effects of Transcutaneous Electrical Acupoint Stimulation on emergence agitation and inflammatory cytokines in patients undergoing thoracoscopic surgery

Phase 1
Recruiting
Conditions
lung disease
Registration Number
ITMCTR2100004892
Lead Sponsor
Hebei General Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1. Patients who intend to undergo thoracoscopic surgery under general anesthesia;
2. Aged 25-70 years, gender and weight are not limited;
3. American Society of Anesthesiologists ASA classification I-III, no history of serious systemic diseases;
4. The operation time is estimated to be about 2 hours;
5. Those who agree to accept this trial and sign an informed consent form.

Exclusion Criteria

1. Those who have local infection or chronic inflammation on the surface of the acupoint stimulation site, or who cannot stick electrode pads;
2. The adjacent nerves of acupoints such as median, ulnar and radial nerves are confirmed to have functional impairment and hypoesthesia due to cervical spondylosis or trauma;
3. It is expected that there is a difficult airway (such as abnormal airway grading, menthol spacing, mouth opening, etc.) or difficult extubation or short-term failure to extubate the tube due to the patient's own factors;
4. Those who have recently received acupoint stimulation or treatment or have been significantly insensitive to acupoint stimulation treatment in the past;
5. Severe lung infection, bronchial inflammation, high airway response, and large amount of sputum are expected to have a greater impact on postoperative extubation.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Interleukin 6;Interleukin 10;
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath